NIH Funding Award

NIH Funding Award

Plakous received award notice from NIH on a $1.7 Million Fast-Track SBIR grant to develop product for NEC.

read more
FDA Designations

FDA Designations

Plakous Therapeutics, Inc is pleased to announce that they have received Orphan Drug and Rare Pediatric Disease designations from the FDA for their lead indication, NEC.

read more
CED Venture Connect

CED Venture Connect

Plakous Therapeutics was selected to present on the main stage at the 2020 Venture Connect Summit in Raleigh, NC.

read more
SEBIO

SEBIO

Plakous was selected as an Early Stage Presenter at the November 2019 SEBio Investor and Partnering Forum in Miami, FL.

read more
RESI Boston

RESI Boston

Plakous was selected as an Global Innovation Challenge Finalist at the September 2018 RESI Boston meeting.

read more

Get in Touch

Get the latest on business and research information.